Fox Lake Towing and Recovery

AstraZeneca’s Brilinta Fails to Win FDA Approval

by on Dec.17, 2010, under Towing

AstraZeneca

The FDA disappointed AstraZeneca and its investors by not approving its heart drug Brilinta, a blood-thinner that the company — facing a severe patent cliff — has high hopes for. If approved, it could be a multibillion-dollar blockbuster. But the FDA wants to see more analyses of results from a major study.

Continue reading AstraZeneca’s Brilinta Fails to Win FDA Approval

AstraZeneca’s Brilinta Fails to Win FDA Approval originally appeared on DailyFinance on Fri, 17 Dec 2010 08:08:00.

Filed Under: , , , , , ,

:, , , , , , , , , , , , , , , , , , , , ,

Leave a Reply

You must be logged in to post a comment.

Looking for something?

Use the form below to search the site:

Still not finding what you're looking for? Drop a comment on a post or contact us so we can take care of it!